These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Exempt 2006-005249-13 Influence of the OATP1B1 genotype on the hepatic uptake of Primovist® in healthy volunteers and in patients with liver disease 2010-12-06 not-yet-due
Completed, but no date Terminated 2007-001796-11 None bad-data
Listed as ongoing, but also has a completion date 2009-013294-18 Magnesiumsulfate in the prevention of post-ERCP pancreatitis – a prospective randomized, placebo-controlled multicenter study 2020-08-31 bad-data
Ongoing 2009-018077-31 A PHASE I/II DOSE SCHEDULE FINDING STUDY FOR CH14.18/CHO CONTINUOUS INFUSION COMBINED WITH SUBCUTANEOUS ALDESLEUKIN (IL-2) IN PATIENTS WITH PRIMARY REFRACTORY OR RELAPSING NEUROBLASTOMA not-yet-due
Not reported 2014-000588-42 PHASE II STUDY OF MONOCLONAL ANTIBODY CH14.18/CHO CONTINUOUS INFUSION IN PATIENTS WITH PRIMARY REFRACTORY OR RELAPSED NEUROBLASTOMA Phase-II-Studie zur kontinuierlichen Infusion des monoklonalen An... 2021-08-10 due-trials
Completed, report not yet due Terminated 2015-001434-16 A method for measuring volume changes of the alveolar ridge during dental implantation using 3D scanning 3D-oberflächenscanbasierte Verlaufsmessung der Extraktionsalveole nach Alveolenmanagement be... 2023-05-08 not-yet-due
Not reported 2017-001083-38 Combined treatment with Nivolumab and Trabectedin in patients with metastatic or inoperable soft tissue Sarcomas - The NiTraSarc Phase II Trial 2022-02-12 due-trials